Germany is set to lead the European rollout of the Wegovy pill, with the oral GLP-1 medication launching in September. This marks a shift from the traditional injectable format of the weight loss treatment.
According to FoodNavigator Europe, other European markets are expected to follow suit, though further rollouts are not planned until late 2026.
